About Futuremeds sp. z o.o
"Futuremeds tworzy sieć nowoczesnych przychodni zajmujących się prowadzeniem badań klinicznych. Naszym priorytetem jest bezpieczeństwo i zdrowie pacjentów. Prowadzimy programy bezpłatnych badań i konsultacji, dzięki czemu pacjenci mają łatwy dostęp do wczesnej diagnostyki, a po spełnieniu odpowiednich kryteriów i wyrażeniu zgody mogą wziąć udział w prowadzonych przez nas badaniach klinicznych zyskując szansę na skorzystanie z najnowocześniejszych leków oraz terapii. Działamy zgodnie ze standardami Dobrej Praktyki Klinicznej GCP i nieustannie się rozwijamy, aby zapewnić naszym pacjentom jak najlepszą opiekę. Nasz zespół tworzą profesjonaliści doświadczeni w prowadzeniu badań klinicznych."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Averitas Pharma, Inc.
1
Bayer
1
Ionis Pharmaceuticals, Inc.
1
Janssen Research & Development, LLC
1
Pfizer
1
Clinical Trials at Futuremeds sp. z o.o
During the past decade, Futuremeds sp. z o.o conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
2020-06-15
2024-02-20
Active, not recruiting
254
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain
2021-01-22
2021-10-18
Terminated
154
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
2021-07-13
2024-04-01
Recruiting
408
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
2021-10-25
2025-02-01
Recruiting
540
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Futuremeds sp. z o.o" #1 sponsor was "Averitas Pharma, Inc." with 1 trials, followed by "Bayer" with 1 trials
sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Futuremeds sp. z o.o
According to Clinical.Site data, the most researched conditions in "Futuremeds sp. z o.o" are
"Crohn's Disease" (1 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials), "Nonalcoholic Fatty Liver Disease" (1 trials), "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials) and "Post Surgical Neuropathic Pain" (1 trials). Many other conditions were trialed in "Futuremeds sp. z o.o" in a lesser frequency.
Clinical Trials Intervention Types at Futuremeds sp. z o.o
Most popular intervention types in "Futuremeds sp. z o.o" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BAY1817080" (1 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Futuremeds sp. z o.o
The vast majority of trials in "Futuremeds sp. z o.o" are
5 trials for "All" genders.
Clinical Trials Status at Futuremeds sp. z o.o
Currently, there are NaN active trials in "Futuremeds sp. z o.o".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Futuremeds sp. z o.o,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Futuremeds sp. z o.o, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".